(Q38902559)

7 September 2017

1 reference

title

Immune regulation in chronic hepatitis C virus infection (English)

1 reference

7 September 2017

1 reference

1 reference

1 reference

Nick Schou Nielsen

3

0 references

Hans J Hartling

object named as

Hans Jakob Hartling

1

0 references

Susanne D Nielsen

object named as

Susanne Dam Nielsen

5

0 references

Julie Christine Gaardbo

4

object named as

Julie Christine Gaardbo

1 reference

7 September 2017

author name string

Vibe Cecilie Ballegaard

2

1 reference

7 September 2017

publication date

19 July 2016

1 reference

Scandinavian Journal of Gastroenterology

7 September 2017

published in

1 reference

7 September 2017

volume

51

1 reference

7 September 2017

issue

11

1 reference

7 September 2017

page(s)

1387-1397

1 reference

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

T cell responses in hepatitis C: the good, the bad and the unconventional

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Protective immunity against hepatitis C: many shades of gray.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

HIV and hepatitis C virus co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Tetramer enrichment reveals the presence of phenotypically diverse hepatitis C virus-specific CD8+ T cells in chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Decoding cell death signals in liver inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Natural killer and natural killer T cells in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Natural killer cells in viral hepatitis: facts and controversies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Natural killer cells: multifaceted players with key roles in hepatitis C immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

NK cells prevalence, subsets and function in viral hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Foxp3 expression in liver correlates with the degree but not the cause of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Regulatory T cells and viral liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Failure of innate and adaptive immune responses in controlling hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatitis C virus induces regulatory T cells by naturally occurring viral variants to suppress T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Interleukin-10 therapy--review of a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

IL-10: the master regulator of immunity to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

T-regulatory lymphocytes and chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

HCV core-mediated activation of latent TGF-β via thrombospondin drives the crosstalk between hepatocytes and stromal environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Molecular mechanism and treatment of viral hepatitis-related liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Origins and Mechanisms of miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

microRNA regulation of inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Biological functions of microRNAs: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Complex interactions between microRNAs and hepatitis B/C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Extracellular miRNAs: the mystery of their origin and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Cell-to-cell miRNA transfer: from body homeostasis to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Interferon modulation of cellular microRNAs as an antiviral mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Regulation of the hepatitis C virus genome replication by miR-199a.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MicroRNAs in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

miR-155: an ancient regulator of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Modulation of TLR 3, 7 and 8 expressions in HCV genotype 3 infected individuals: potential correlations of pathogenesis and spontaneous clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Suppression of type I collagen production by microRNA-29b in cultured human stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

New direct-acting antivirals' combination for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Regulatory phenotype, PD-1 and TLR3 expression in T cells and monocytes from HCV patients undergoing antiviral therapy: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Restoration of HCV-specific CD8+ T cell function by interferon-free therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

T-cell homeostasis in chronic HCV-infected patients treated with interferon and ribavirin or an interferon-free regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

CD4+ and CD8+ Regulatory T Cells (Tregs) are Elevated and Display an Active Phenotype in Patients with Chronic HCV Mono-Infection and HIV/HCV Co-Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

EASL Recommendations on Treatment of Hepatitis C 2015

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2016.1170875

10.3109/00365521.2016.1170875

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference